IntelGenx announces multiple commercialization agreements with Chemo Group in 2017

By Melissa Fassbender contact

- Last updated on GMT

Related tags: Corporation

Founded in 1978, Chemo Group markets more than 300 products.(Image: Chemo Group)
Founded in 1978, Chemo Group markets more than 300 products.(Image: Chemo Group)
IntelGenx Corp has granted Chemo Group an exclusive worldwide license to commercialize several products – moving the company into the novel drug delivery market.

Chemo has signed four products with us in 2017​,” Edward Miller, Director, IR and Corporate Communications at IntelGenx, told Outsourcing-Pharma.com. “We will work with Chemo to develop these products to commercialization​.”

According to the oral drug delivery company company, the combined total market of the four products is more than $7bn. The partnership could also present future opportunities for further product agreements.

Per the agreement, IntelGenx is entitled to an upfront payment, development costs of the product and future milestone payments. A total value of which is in the seven digits, according to IntelGenx.

The companies will share the commercialization profits.

IntelGenx also recently built a new oral film development and manufacturing facility in Montreal, Canada. Construction was completed in Q1 2016 and the facility is expected to be fully operational by Q1 2017. The 17,000 sq ft facility features high capacity manufacturing and packaging equipment.

Related news

Related products

show more

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Keys To A Successful Rapid Commercial Launch

Keys To A Successful Rapid Commercial Launch

Catalent Pharma Solutions | 21-Oct-2020 | Insight Guide

Pharma and biotech companies are dedicating resources to new treatments with the hope of helping patients. The quicker they can get products to patients,...

Related suppliers

Follow us

Products

View more

Webinars